Lung cancer screening is recommended only for those who are at high risk for the disease—adults ages 50–80 who smoke at least 20 packs a year—but even among members of that high-risk group, screening rates remain ...
Nov 16, 2021
0
2
A parallel randomized controlled trial confirmed that a single flexible sigmoidoscopy screening at age 55 to 64 years represents a safe and effective strategy associated with a substantial reduction in colorectal cancer (CRC) ...
Nov 9, 2021
0
1
George Washington University researchers have identified a key molecule in certain kinds of breast cancers that prevent immune cells from entering tumors and killing the cancer cells inside. The paper and its findings, published ...
Nov 3, 2021
0
191
How does cancer affect immunity against COVID-19, even if a person is vaccinated? It's a question that's been on the minds of many since Colin Powell's death from COVID-19 complications after battling multiple myeloma.
Oct 25, 2021
0
3
(HealthDay)—Cancer survivors appear to experience variable benefit from an eHealth self-management program designed to increase self-efficacy for managing cancer-related issues, according to a study published online Oct. ...
Oct 20, 2021
0
1
COVID-19 vaccine choices are getting more complicated. So don't feel bad if you are confused about the different COVID-19 vaccines and who's eligible for what. In addition to the three original vaccines approved by the Food ...
Oct 8, 2021
0
41
Findings from a national study by researchers at Translational Genomics Research Institute (TGen), an affiliate of City of Hope, and external collaborators suggest that sex and age are crucial factors in the care and survival ...
Sep 22, 2021
0
42
Low-dose CT lung cancer (LDCT) screening is associated with a 16 percent relative reduction in lung cancer mortality, when compared against a non-LDCT control arm, according to research presented by Professor John Field and ...
Sep 12, 2021
0
8
A combination of metformin and chemoradiation in patients with locally advanced non-small cell lung cancer (LA-NSCLC) was not found to add survival benefit in the NRG Oncology clinical trial NRG-LU001. These results were ...
Aug 24, 2021
0
283
(HealthDay)—The seropositivity rate among patients with cancer remains high four months after the second dose of the COVID-19 vaccine, according to a research letter published online Aug. 11 in JAMA Oncology.
Aug 23, 2021
0
2
